CD8A and neoplasm: Processing of extracellular tumor-derived antigens into peptides and cross-presentation of neo-epitopes onto cell surface class I MHC molecules by antigen presenting cells (APC), such as dendritic cells (DCs), is critical for activation of cytotoxic CD8+ T cells.